CHRM1
Basic information
Region (hg38): 11:62908679-62921807
Links
Phenotypes
GenCC
Source:
- intellectual disability (Limited), mode of inheritance: AD
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CHRM1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 6 | |||||
missense | 22 | 23 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 1 | 23 | 3 | 2 |
Variants in CHRM1
This is a list of pathogenic ClinVar variants found in the CHRM1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-62909734-G-A | not specified | Uncertain significance (May 09, 2023) | ||
11-62909747-C-T | not specified | Uncertain significance (Aug 30, 2021) | ||
11-62909758-C-T | not specified | Uncertain significance (Mar 15, 2024) | ||
11-62909794-C-T | not specified | Uncertain significance (Aug 27, 2024) | ||
11-62909824-C-T | not specified | Uncertain significance (Dec 01, 2022) | ||
11-62909827-A-G | See cases • CHRM1-related neurodevelopmental disorder | Likely pathogenic (Jul 30, 2024) | ||
11-62909964-T-G | Benign (Apr 24, 2018) | |||
11-62909990-G-A | not specified | Uncertain significance (Feb 12, 2024) | ||
11-62910089-C-T | not specified | Uncertain significance (Jul 02, 2024) | ||
11-62910100-C-T | not specified | Uncertain significance (Jun 03, 2022) | ||
11-62910110-T-G | not specified | Uncertain significance (Oct 12, 2024) | ||
11-62910115-G-A | not specified | Uncertain significance (Jun 21, 2021) | ||
11-62910253-C-A | not specified | Uncertain significance (Oct 13, 2023) | ||
11-62910258-G-A | Benign (Dec 31, 2019) | |||
11-62910325-C-A | not specified | Uncertain significance (Dec 15, 2023) | ||
11-62910364-G-C | not specified | Uncertain significance (Aug 12, 2021) | ||
11-62910369-A-T | Likely benign (Jun 05, 2018) | |||
11-62910410-G-A | not specified | Uncertain significance (May 08, 2024) | ||
11-62910411-C-T | Likely benign (May 24, 2018) | |||
11-62910437-G-C | not specified | Uncertain significance (Aug 16, 2021) | ||
11-62910463-C-T | not specified | Uncertain significance (Dec 06, 2023) | ||
11-62910483-C-T | Uncertain significance (Mar 01, 2017) | |||
11-62910662-C-T | not specified | Uncertain significance (Aug 22, 2023) | ||
11-62910692-G-A | not specified | Uncertain significance (Sep 01, 2021) | ||
11-62910863-T-G | Uncertain significance (Mar 23, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CHRM1 | protein_coding | protein_coding | ENST00000306960 | 1 | 13129 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.991 | 0.00941 | 121991 | 0 | 1 | 121992 | 0.00000410 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.76 | 160 | 293 | 0.546 | 0.0000191 | 2935 |
Missense in Polyphen | 21 | 78.339 | 0.26807 | 864 | ||
Synonymous | 0.285 | 116 | 120 | 0.967 | 0.00000725 | 1017 |
Loss of Function | 3.47 | 0 | 14.0 | 0.00 | 7.56e-7 | 142 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00000901 | 0.00000901 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: The muscarinic acetylcholine receptor mediates various cellular responses, including inhibition of adenylate cyclase, breakdown of phosphoinositides and modulation of potassium channels through the action of G proteins. Primary transducing effect is Pi turnover.;
- Pathway
- PI3K-Akt signaling pathway - Homo sapiens (human);Regulation of actin cytoskeleton - Homo sapiens (human);Calcium signaling pathway - Homo sapiens (human);cAMP signaling pathway - Homo sapiens (human);Neuroactive ligand-receptor interaction - Homo sapiens (human);Cholinergic synapse - Homo sapiens (human);Secretion of Hydrochloric Acid in Parietal Cells;Focal Adhesion-PI3K-Akt-mTOR-signaling pathway;PI3K-Akt Signaling Pathway;GPCRs, Class A Rhodopsin-like;Regulation of Actin Cytoskeleton;Calcium Regulation in the Cardiac Cell;Monoamine GPCRs;Signaling by GPCR;Signal Transduction;ion channels and their functional role in vascular endothelium;activation of csk by camp-dependent protein kinase inhibits signaling through the t cell receptor;chrebp regulation by carbohydrates and camp;role of -arrestins in the activation and targeting of map kinases;activation of camp-dependent protein kinase pka;Muscarinic acetylcholine receptors;Amine ligand-binding receptors;Class A/1 (Rhodopsin-like receptors);roles of arrestin dependent recruitment of src kinases in gpcr signaling;actions of nitric oxide in the heart;GPCR ligand binding;agrin in postsynaptic differentiation;-arrestins in gpcr desensitization;G alpha (q) signalling events;GPCR downstream signalling
(Consensus)
Recessive Scores
- pRec
- 0.531
Intolerance Scores
- loftool
- rvis_EVS
- -0.69
- rvis_percentile_EVS
- 14.97
Haploinsufficiency Scores
- pHI
- 0.258
- hipred
- Y
- hipred_score
- 0.707
- ghis
- 0.618
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.395
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Chrm1
- Phenotype
- endocrine/exocrine gland phenotype; immune system phenotype; homeostasis/metabolism phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); digestive/alimentary phenotype;
Gene ontology
- Biological process
- cellular protein modification process;signal transduction;G protein-coupled receptor signaling pathway;G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger;adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway;protein kinase C-activating G protein-coupled receptor signaling pathway;phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway;G protein-coupled acetylcholine receptor signaling pathway;chemical synaptic transmission;neuromuscular synaptic transmission;nervous system development;cell population proliferation;positive regulation of cell population proliferation;regulation of locomotion;positive regulation of ion transport;saliva secretion;cognition;regulation of postsynaptic membrane potential;positive regulation of intracellular protein transport;G protein-coupled serotonin receptor signaling pathway
- Cellular component
- plasma membrane;integral component of plasma membrane;membrane;cell junction;dendrite;axon terminus;Schaffer collateral - CA1 synapse;glutamatergic synapse;cholinergic synapse;integral component of presynaptic membrane;integral component of postsynaptic density membrane
- Molecular function
- phosphatidylinositol phospholipase C activity;G protein-coupled receptor activity;G protein-coupled serotonin receptor activity;drug binding;G protein-coupled acetylcholine receptor activity;neurotransmitter receptor activity;neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential